MedPath
NMPA Approval

Alprostadil for Injection

国药准字H20178013

June 13, 2022

国药准字H20178013

Drug Information

注射用前列地尔

注射剂

0.1mg

化学药品

June 13, 2022

Company Information

Applicant Company

广州市黄埔区东区东博路6号自编一栋自编101房

Manufacturing Company

广州市经济技术开发区东区东博路6号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用前列地尔 - NMPA 批准文号 | MedPath